We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,716.00
Bid: 1,715.50
Ask: 1,716.50
Change: 11.00 (0.65%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,717.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Miners pull UK markets lower, but Smith & Nephew rises

Fri, 30th May 2014 11:34

- Mining stocks lower on iron ore, China concerns- Fenner issues profit warning- M&A continues to boost Smith & NephewtechMARK 2,820.23 +0.39%FTSE 100 6,860.62 -0.16%FTSE 250 16,039.31 +0.53%Weakness in the mining sector dragged the UK stock market from a two-week high on Friday, despite M&A speculation boosting the share prices of Smith & Nephew and Salamander Energy.Mining stocks were trading firmly in the red as iron ore prices were headed for their sixth consecutive monthly decline, the longest losing streak on record. Meanwhile, concerns about a slowdown in China were also having an impact on stocks, as well as a profit warning from polymer products group Fenner, which makes conveyor belts for the mining industry."[Chinese] government figures indicated manufacturing growth was weakening, contradicting recent signs of improvement in the economy and providing an excuse for some selling in raw materials," said Chris Beauchamp, Market Analyst at IG.The FTSE 100 was down 0.2% at 6,861 by midday after hitting 6,871.29 on Thursday, its highest close since May 14th when it reached a new 14-year high of 6,878.49.Investors were also focusing on a batch of mixed economic data from across the globe, including an improvement in consumer confidence in the UK, weak industrial production figures and stronger-than-expected inflation in Japan, and an unexpected dip in retail sales in Germany.Miners weigh on markets, Fenner plummetsRising iron ore supplies from Australia and Brazil have prompted a 9% fall in prices this month, with the value of the commodity having now fallen every month since December. This is the longest string of monthly losses since data from The Steel Index Ltd began in November 2008, according to Bloomberg. Diversified miners Anglo American, BHP Billiton and Rio Tinto were among the worst performers on the FTSE 100, with concerns over China also dampening sentiment.In another hit to sentiment in the mining industry, Fenner issued a profit warning, causing shares to sink sharply. The group said annual profits would be 10-15% below market expectations on the back of weakness in the US coal industry, prompting analysts at Numis Securities to downgrade the stock from 'add' to 'hold'.Meanwhile, solid fuel supplier and logistics group Hargreaves Services also fell after saying results from its Production Division will be below expectations this year due to "challenging trading conditions" in coke markets and delays.Medical device maker Smith & Nephew was on the rise as bid speculation continued to drive the stock higher. While US peer Stryker was forced to publicly deny reports that it was working on a bid for the company, its boss yesterday confirmed in an interview that the company had in fact been in the early stages of considering a transaction but was not ready to make an offer. UBS this morning added the stock to its 'M&A Watch List'.GlaxoSmithKline was fluctuating between gains and losses on rumours that it has approached a number of private equity firms to gauge the interest for a range of its older drugs as it attempts to refresh its portfolio. AIM-listed oil explorer Petroceltic was trading lower after giving investors a trio of "disappointing" updates from its international drilling programme. Meanwhile, sector peer Salamander Energy surged on reports that Cia Espanola de Petroleos SAU is looking to buy to company for €700m.DIY retailer Kingfisher was continuing to fall after an underwhelming first-quarter statement yesterday as Barclays Capital cut the shares to 'equal weight' and trimmed its target price.FTSE 100 - RisersSmith & Nephew (SN.) 1,055.00p +2.53%Coca-Cola HBC AG (CDI) (CCH) 1,390.00p +1.83%Admiral Group (ADM) 1,454.00p +1.82%Hammerson (HMSO) 601.00p +1.18%Whitbread (WTB) 4,182.00p +1.06%Persimmon (PSN) 1,340.00p +1.06%Sports Direct International (SPD) 800.00p +0.88%Land Securities Group (LAND) 1,071.00p +0.85%Sage Group (SGE) 415.10p +0.80%St James's Place (STJ) 786.00p +0.77%FTSE 100 - FallersRio Tinto (RIO) 3,104.50p -2.63%Anglo American (AAL) 1,505.50p -2.56%Fresnillo (FRES) 814.00p -2.52%BHP Billiton (BLT) 1,904.00p -1.88%Morrison (Wm) Supermarkets (MRW) 199.10p -1.53%Antofagasta (ANTO) 795.50p -1.12%Royal Mail (RMG) 512.50p -1.06%G4S (GFS) 250.30p -1.03%Kingfisher (KGF) 393.10p -0.98%Barratt Developments (BDEV) 356.50p -0.94%FTSE 250 - RisersOphir Energy (OPHR) 266.50p +4.02%Micro Focus International (MCRO) 843.00p +3.56%CSR (CSR) 597.50p +3.55%Euromoney Institutional Investor (ERM) 1,178.00p +3.51%Ocado Group (OCDO) 385.20p +3.41%Supergroup (SGP) 1,145.00p +3.25%Xaar (XAR) 847.00p +3.17%Afren (AFR) 154.10p +3.15%Rank Group (RNK) 160.80p +3.08%Perform Group (PER) 272.50p +2.83%FTSE 250 - FallersFenner (FENR) 349.30p -10.37%Paragon Group Of Companies (PAG) 376.80p -3.09%Evraz (EVR) 107.00p -2.01%Drax Group (DRX) 627.00p -1.49%Vedanta Resources (VED) 1,112.00p -1.33%Smith (DS) (SMDS) 318.90p -1.33%Tate & Lyle (TATE) 693.50p -1.14%Playtech (PTEC) 665.00p -1.12%Ferrexpo (FXPO) 137.50p -1.08%TalkTalk Telecom Group (TALK) 318.50p -1.06%BC
More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.